Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transplant rejection averted by simple light exposure in Stanford animal study

06.05.2004


One of the unfortunate side effects of bone marrow and stem cell transplantation is that the newly implanted cells often stage an internal attack against the patient they’re intended to help. Stanford University School of Medicine researchers now have a better grasp of this phenomenon, known as graft-versus-host disease, or GVHD, and have proposed a possible method of prevention: simple ultraviolet light.



In a new animal study, researchers identified the principal culprit in GVHD: an immune cell in the skin known as a Langerhans cell. These cells normally function as flag posts for the immune system, signaling infection-fighting T-cells to come to a particular site to fight off a virus or bacteria. But in transplants, they do patients a great disservice, alerting T-cells to attack the patient’s own tissues, researchers found.

The researchers were able to effectively eliminate the Langerhans cells in transplanted mice by exposing them to ultraviolet light, giving the animals mild sunburn. Transplanted mice that received this treatment experienced no GVHD while those that didn’t showed severe signs of the disease, said Edgar Engleman, MD, professor of pathology and medicine and senior author of the study.


"The experiment not only provided the proof that these cells cause graft-versus-host disease, but also provides a way of thinking about how you might prevent it," said Engleman, who also directs the Stanford Blood Center. The study appears in the May issue of the journal Nature Medicine.

Bone marrow or stem cell transplants are commonly used to treat patients with cancers of the blood system, such as leukemia, lymphoma or myeloma. Patients first receive radiation treatment to wipe out their defective immune systems, which then are replaced by healthy donor cells.

Sometimes, however, the process fails as GVHD sets in. The effects of the disease are most commonly seen in the skin as a reddish rash or, in more severe cases, as skin that blisters and peels.

The Stanford scientists first suspected that Langerhans cells might have a major role in GVHD after their earlier experiments showed these cells were resistant to radiation and persisted in the skin for a long time, said Miriam Merad, MD, PhD, a former postdoctoral scholar in Engelman’s lab and the first author of the study. The discovery was "shocking," Engleman said, as all other white blood cells have a short half-life and are frequently replaced. The Langerhans cells don’t change unless they’re disturbed in some way, say by inflammation, he said.

The scientists surmised that these cells might linger in the skin of a transplant patient and instigate trouble. Their latest experiments bore this out.

The researchers tested their theory in two different sets of mice. In one group, the animals had their own Langerhans cells intact. When these animals were transplanted, the Langerhans cells triggered a response and the mice developed severe GVHD. In a second group, the scientists replaced the animals’ Langerhans cells with other cells. When these mice underwent transplant, they remained protected from GVHD.

The scientists took it a step further. They exposed the vulnerable mice - those with their own Langerhans cells - to ultraviolet light using a sunlamp. The sun exposure depleted the Langerhans cells and effectively protected the mice from the disease, said Merad, who is now based at the Mount Sinai School of Medicine.

The researchers said the results present a promising option for transplant patients and could be the basis for clinical trials in which patients are exposed to ultraviolet light before treatment.

"What we would do is try to eliminate the host Langerhans cells before the transplant, as we did in the mice," Merad said. She noted that dermatologists now use ultraviolet light to treat some skin diseases, administering it to patients inside a chamber under controlled circumstances to avoid burning.

Engleman said the ultraviolet treatment would have to be carefully administered to patients before bone marrow or stem cell transplantation to avoid harmful side effects. "The trick is deplete the host Langerhans cells in a manner that doesn’t cause other unwanted effects," he said.


Other Stanford researchers in the study include Petra Hoffman, PhD; Erik Ranheim, MD, PhD; Markus G. Manz, MD; Irving Weissman, MD; and Samuel Strober, MD. Other collaborators included Sarah Slaymaker and Israel Charo, MD, PhD, of UCSF; Sergio A. Lira, MD, PhD, of Mount Sinai; and Donald N. Cook, MD, of Duke University.

The study was funded by the National Institutes of Health and by a grant from the Irene Diamond Fund.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.

Ruthann Richter | EurekAlert!
Further information:
http://mednews.stanford.edu

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>